Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
JAMA Network Open|May 19, 2023
Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical TrialLama Ghazi, Jincheng Shen, Jian Ying, et al.
JAMA Network Open|January 28, 2022
Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive ImpairmentZachary A Marcum, Jordana B Cohen, Chong Zhang, et al.
JAMA Network Open|July 14, 2022
Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT)Jordana B Cohen, Zachary A Marcum, Chong Zhang, et al.
Hypertension (Dallas, Tex. : 1979)|December 15, 2022
Antihypertensive Medication Regimens Used in the Systolic Blood Pressure Intervention TrialCatherine G Derington, Adam P Bress, Andrew E Moran, et al.
JAMA Network Open|February 14, 2022
Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin TreatmentWilliam S Weintraub, Deepak L Bhatt, Zugui Zhang, et al.
American Journal of Hypertension|June 28, 2023
Estimated Population Health Benefits of Intensive Systolic Blood Pressure Treatment Among SPRINT-Eligible US AdultsCatherine G Derington, Adam P Bress, Ransmond O Berchie, et al.
Journal of the American College of Cardiology|April 23, 2021
Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse EventsAdam P Bress, Tom Greene, Catherine G Derington, et al.
American Heart Journal Plus : Cardiology Research and Practice|March 7, 2022
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and COVID-19-related outcomes: A patient-level analysis of the PCORnet blood pressure control labSteven M Smith, Raj A Desai, Marta G Walsh, et al.
Hypertension (Dallas, Tex. : 1979)|July 2, 2019
Association of Total Medication Burden With Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINTCatherine G Derington, Tyler H Gums, Adam P Bress, et al.
Plos One|April 23, 2021
Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US VeteransCatherine G Derington, Jordana B Cohen, April F Mohanty, et al.
Pageof 6